4//SEC Filing
Taveras Arthur 4
Accession 0001628280-23-036463
CIK 0001501697other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 4:59 PM ET
Size
5.0 KB
Accession
0001628280-23-036463
Insider Transaction Report
Form 4
Taveras Arthur
Chief Scientific Officer
Transactions
- Award
Common Stock
2023-10-31+230,645→ 317,018 total
Footnotes (1)
- [F1]Represents shares earned upon the vesting of performance-based restricted stock units. The Compensation Committee of the Board of Directors of the Issuer certified the achievement of a performance condition, which occurs upon FDA acceptance of a new drug application for mavorixafor.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001830901
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 4:59 PM ET
- Size
- 5.0 KB